Angiogenic and lymphangiogenic profiles in histological variants of papillary thyroid carcinoma

Pol Arch Intern Med. 2017 Jun 30;127(6):429-437. doi: 10.20452/pamw.3999. Epub 2017 Apr 20.

Abstract

Introduction: Papillary thyroid carcinoma (PTC) is a well‑differentiated tumor that occurs in several histological variants whose biological behaviors remain unclear. Angiogenesis and lymphangiogenesis are critical processes that enable tumor progression.

Objectives: The aim of this study was to evaluate the angiogenic and lymphangiogenic phenotypes of PTC, considering the differences between histological variants.

Patients and methods: Angiogenic and lymphangiogenic profiles were analyzed by determining microvascular density (MVD) and lymphatic vessel density (LVD) in 73 cases of PTC, using immunohistochemistry. To assess the biological markers involved in blood and lymph vessel formation, the expression of vascular endothelial growth factor (VEGF), cyclooxygenase 2 (COX‑2), and p27kip1 (p27) was determined.

Results: MVD was significantly higher in patients with high‑risk PTC and in those with local extrathyroidal and vascular invasion. Positive VEGF expression was strongly associated with high MVD and age‑related tumor enlargement. The presence of lymph vessel invasion was associated with the expression of either VEGF or COX‑2. The analysis of angiogenesis and lymphangiogenesis in different histological variants of PTC revealed elevated LVD rather than MVD in the follicular variant of PTC (FV‑PTC).Lower MVD was observed in FV‑PTC relative to the classic variant of PTC (CV‑PTC). The frequency of VEGF‑positive tumors was higher in CV‑PTC than in FV‑PTC. A significant association between COX‑2 and p27 expression was observed in FV‑PTC but not in CV‑PTC.

Conclusions: These results suggest that VEGF, COX‑2, and p27 may be important biological markers that determine the angiogenic and lymphangiogenic potentials of PTC, particularly between the follicular and classic variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • Cyclin-Dependent Kinase Inhibitor p27 / analysis*
  • Cyclooxygenase 2 / analysis*
  • Female
  • Humans
  • Lymphangiogenesis*
  • Male
  • Middle Aged
  • Neovascularization, Pathologic*
  • Thyroid Cancer, Papillary / blood supply*
  • Thyroid Cancer, Papillary / enzymology
  • Thyroid Cancer, Papillary / metabolism
  • Thyroid Cancer, Papillary / pathology
  • Thyroid Neoplasms / blood supply*
  • Thyroid Neoplasms / enzymology
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / pathology
  • Vascular Endothelial Growth Factor A / analysis*

Substances

  • Biomarkers
  • Vascular Endothelial Growth Factor A
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclooxygenase 2